Public Citizen Pushes Against Approval Of Twice-Rejected Drug

Public Citizen urged FDA to reject for the third time a Ferring Pharmaceuticals drug manufactured to treat frequent nighttime urination, which the consumer group says dangerously lowers blood sodium levels. According to the group's press release, the drug, Nocdurna, has been rejected twice before because the product's effect in reducing nighttime urination was determined to be modest and unclear as compared with a placebo. After Ferring submitted a third application, an FDA reviewer commenting on the quality-of-life effects concluded that...